In the News

Melanoma Vaccine Showing Promise

October 28, 2026

By Terri Russell

RENO, Nev. (KOLO) -A breakthrough in the treatment of malignant melanoma, the most dangerous and deadliest form of skin cancer.

Studies on a new vaccine to treat this skin cancer will be submitted to the Food and Drug Administration in December for approval

The technology uses the MRNA vaccine. Most of us are familiar with that immunization as it was used during COVID to help ward off the virus.

Jana Duplantis says like most folks in her generation she used to lay out in the sun or even used sunbeds. Little did she know she was setting herself up for skin cancer.

Seven lesions to be exact all melanoma to be exact. There was one even on her foot.

Now she visits her doctor every three months and crosses her fingers.

“My husband would call and say let me know what happens,” says Duplantis. “Even though I wouldn’t know until labs came back. He would say good luck, and I hope it’s just taking it off, and it’s fine, and it comes back ok,” she says of the lesions doctors frequently have to remove from her skin.

Duplantis says she got excited when she heard about a melanoma vaccine that is showing promise in preventing and curtailing melanoma.

Digging deeper she found fortunately for her, she wouldn’t qualify for such a treatment.

“It is not for everyone who has melanoma,” says Dermatologist, Dr. Cindy Lamerson MD, with Nevada Center for Dermatology. “It is for the advanced cases.”

The vaccine uses MRNA technology to treat melanoma.

Dr. Lamerson says each vaccine is developed to the individual patient. Defective proteins on the cancer cell are separated out, that along with an immunology drug will direct the immune cells to recognize mutated proteins on cancer cells and kill them.

“It can fight against the cancer and actually reduce it,” says Dr. Lamerson.

Lamerson says because the vaccine is so personalized the treatment will be expensive. hundreds of thousands of dollars.

This is why the therapy is not ideal for early-stage melanoma as they can be cured with surgical removal of the tumor.

With the MRNA and immunology drug combined, Lamerson says there’s a decrease in recurrence and death by 42%.

View the article on KOLO News 8

  Back to News